Literature DB >> 7258489

Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes.

T W Holbrook, J A Cook, B W Parker.   

Abstract

Mice were immunized by a series of intravenous injections of formalin-killed Leishmania donovani promastigotes alone and combined with glucan, a beta 1,3 polyglucose derivative of baker's yeast. In three separate experiments animals were challenged with viable parasites on day 21, 40 or 80 after immunization. Mice which received dead parasites and glucan exhibited resistance against challenge up to 80 days after immunization. Animals which had been injected with glucan alone exhibited a lesser degree of resistance but injections of killed promastigotes alone conferred no measurable resistance against infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7258489     DOI: 10.4269/ajtmh.1981.30.762

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.

Authors:  Siddhartha Kumar Bhaumik; Manoj Kumar Singh; Subir Karmakar; Tripti De
Journal:  Glycoconj J       Date:  2008-11-13       Impact factor: 2.916

3.  Protective effect of glucan against visceral leishmaniasis in hamsters.

Authors:  J A Cook; T W Holbrook; W J Dougherty
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

4.  Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes.

Authors:  F Afrin; N Ali
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Immunogenicity of soluble and particulate antigens from Leishmania donovani: effect of glucan as an adjuvant.

Authors:  J A Cook; T W Holbrook
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes.

Authors:  J González; M F Araguth; N Yoshida
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development.

Authors:  Nicole Zimara; Menberework Chanyalew; Abraham Aseffa; Ger van Zandbergen; Bernd Lepenies; Maximilian Schmid; Richard Weiss; Anne Rascle; Anja Kathrin Wege; Jonathan Jantsch; Valentin Schatz; Gordon D Brown; Uwe Ritter
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

8.  A review of adjuvants for Leishmania vaccine candidates.

Authors:  Joshua M Mutiso; John C Macharia; Michael M Gicheru
Journal:  J Biomed Res       Date:  2010-01

9.  β-Glucan and Parasites.

Authors:  V Vetvicka; R Fernandez-Botran
Journal:  Helminthologia       Date:  2018-07-28       Impact factor: 1.184

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.